- Report
- November 2024
- 100 Pages
Global
From €5271EUR$5,950USD£4,567GBP
- Report
- May 2025
- 186 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP
- Report
- February 2025
- 200 Pages
Global
From €3977EUR$4,490USD£3,446GBP
- Report
- April 2025
- 175 Pages
Global
From €3977EUR$4,490USD£3,446GBP
- Report
- November 2024
- 150 Pages
Global
From €2879EUR$3,250USD£2,495GBP
€4296EUR$4,850USD£3,723GBP
- Report
- July 2025
- 291 Pages
Global
From €5182EUR$5,850USD£4,490GBP
- Report
- July 2025
- 191 Pages
Global
From €5182EUR$5,850USD£4,490GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1107EUR$1,250USD£959GBP
- Report
- May 2025
- 181 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1107EUR$1,250USD£959GBP
- Report
- May 2025
- 150 Pages
Global
From €5271EUR$5,950USD£4,567GBP
- Report
- May 2025
- 197 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP
- Report
- May 2025
- 189 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP
- Report
- May 2025
- 199 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP
- Report
- May 2025
- 184 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP
- Report
- May 2025
- 197 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP
- Report
- May 2025
- 191 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP
- Report
- May 2025
- 189 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP
- Report
- May 2025
- 197 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP
- Report
- May 2025
- 193 Pages
Global
From €3140EUR$3,545USD£2,721GBP
€3489EUR$3,939USD£3,023GBP

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more